Human and Rat Liver Cytochromes P450
657
interactions with metyrapone and cytochrome b5.
Biochemistry 22, 4846-4855.
223.
Franklin, M.R. (1972). Inhibition of hepatic oxida-
tive xenobiotic metabolism by piperonyl butoxide.
Biochem. Pharmacol. 21, 3287-3299.
224.
Hodgson, E. and R.M. Philpot (1974). Interaction
of methylenedioxyphenyl (1,3-benzodioxole) com-
pounds with enzymes and their effects on mam-
mals.
Drug. Metab. Rev. 3,
231-301.
225.
Buening, M.K. and Franklin, M.R. (1974). The
formation of complexes absorbing at 455 nm from
cytochrome P-450 and metabolites of compounds
related to SKF 525-A. Drug Metab. Dispos. 2,
386-390.
226.
Omura, T. and R. Sato (1964). The carbon monox-
ide-binding pigment of liver microsomes. I.
Evidence for its hemoprotein nature.
J.
Biol. Chem.
239,
2370-2378.
227.
Estabrook, R.W., J.A. Peterson, J. Baron, and A.G.
Hildebrandt (1972). The spectrophotometric
measurement of turbid suspensions of cytochromes
associated with drug metabolism. In C.F. Chignell
(ed.).
Methods in Pharmacology, Vol. 2. Appleton-
Century-Crofts, New
York,
NY, pp. 303-350.
228.
Matsubara, T, M. Koike, A. Touchi, Y. Tochino,
and K. Sugeno (1976). Quantitative determination
of cytochrome P-450 in rat liver homogenate.
Anal. Biochem. 75, 596-603.
229.
Ryan, D.E., RE. Thomas, D. Korzeniowski, and
W. Levin (1979). Separation and characterization
of highly purified forms of liver microsomal
cytochrome P-450 from rats treated with poly
chlo-
rinated biphenyls, phenobarbital, and 3-methyl-
cholanthrene. J 5?o/. Chem. 254, 1365-1374.
230.
Ryan, D.E., S. lida, A.W. Wood, RE. Thomas,
C.S. Lieber, and
W.
Levin (1984). Characterization
of three highly purified cytochromes P-450 from
hepatic microsomes of adult male rats. J. Biol.
Chem.
259, 1239-1250.
231.
Ryan, D.E., RE. Thomas, and W. Levin (1980).
Hepatic microsomal cytochrome P-450 from rats
treated with isosafrole. Purification and character-
ization of four enzymic forms. J. Biol. Chem. 255,
7941-7955.
232.
Jefcoate, C.R. (1978). Measurement of substrate
and inhibitor binding to microsomal cytochrome
P-450 by optical-difference spectroscopy. Meth.
Enzymol 52, 258-279.
233.
Omura, T. and R. Sato (1964). The carbon monox-
ide-binding pigment of liver microsomes. II.
Solubilization, purification, and properties.
J.
Biol.
Chem.
239, 2379-2385.
234.
Elcombe, C.R., J. Bridges, R.H. Nimmo-Smith, and
J. Werringloer (1975). Cumene hydroperoxide-
mediated formation of inhibited complexes of
methylenedioxyphenyl compounds with cytochrome
P450.
Biochem. Soc.
Trans.
3, 967-970.
235.
Philpot, R.M. and E. Hodgson (1972). The effect
of piperonyl butoxide concentration on the forma-
tion of cytochrome P-450 difference spectra in
hepatic microsomes from mice. Mol. Pharmacol.
8, 204-214.
236.
Franklin, M.R. (1977). Inhibition of mixed-fiinc-
tion oxidations by substrates forming reduced
cytochrome P-450 metabolic-intermediate com-
plexes. Pharmacol.
Ther.
A. 2, 227-245.
237.
Franklin, M.R. (1991). Cytochrome P450 meta-
bolic intermediate complexes from macrolide
antibiotics and related compounds. Meth. Enzymol.
206,559-573.
238.
Larrey, D., M. Tinel, and D. Pessayre (1983).
Formation of inactive cytochrome P-450
Fe(II)-metabolite complexes with several erythro-
mycin derivatives but not with josamycin and
midecamycin in rats. Biochem. Pharmacol. 32,
1487-1493.
239.
Delaforge, M., E. Sartori, and D. Mansuy (1988).
In vivo and in vitro effects of a new macrolide
antibiotic roxithromycin on rat liver cyto-
chrome P-450: Comparison with troleandomycin
and erythromycin. Chem. Biol. Interact. 68,
179-188.
240.
Paul, K.G., H. Theorell, and A. Akeson (1953). The
molar light absorption of pyridine ferroprotopor-
phyrin (Pyridine Haemochromogen). Acta. Chem.
Scand.
7, 1284-1287.
241.
Waterman, M.R. (1978). Spectral characterization
of human hemoglobin and its derivatives. Meth.
Enzymol. 52, 456-463.
242.
Klingenberg, M. (1958). Pigments of rat liver
microsomes,
^rc/?.
Biochem. Biophys. 75, 376-386.
243.
Strittmatter, P (1960). The nature of the heme
binding in microsomal cytochrome b5. J. Biol.
Chem.
235, 2492-2497.
244.
Strittmatter, P, P Fleming, M. Connors, and
D.
Corcoran (1978). Purification of cytochrome
b3.
Meth.
Enzymol. 52,
97-101.
245.
Guengerich,
F.P.
(1994).
Analysis and characteriza-
tion of enzymes. In A.W. Hayes (ed.). Principles
and Methods of Toxicology. Raven Press, Ltd.,
New York, NY. pp. 1259-1313.
246.
Phillips, A.H. and R.G. Langdon (1962). Hepatic
triphosphopyridine nucleotide-cytochrome c reduc-
tase:
Isolation, characterization, and kinetic studies.
J. Biol. Chem. 237, 2652-2660.
247.
Strobel, H.W and J.D. Dignam (1978).
Purification and properties of NADPH-
cytochrome P-450 reductase. Meth. Enzymol. 52,
89-96.
248.
Wang, H., R. Dick, H. Yin, E. Licad-Coles, D.
Kroetz, G. Szklarz et al (1998). Structure-function
relationships of human liver cytochromes P450 3 A:
Aflatoxin Bl metabolism as a probe. Biochemistry
37,
12536-12545.